Weaver C. Barksdale & Associates’s Cigna CI Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	6,654 -40	-0.6%	-$11.3K	1.65%	31
2026 Q1	$1.79M	Buy	6,694 +419	+7%	+$116K	1.7%	29
2025 Q4	$1.73M	Buy	6,275 +4,200	+202%	+$1.18M	1.81%	24
2025 Q3	$598K	Hold	2,075	–	–	0.58%	62
2025 Q2	$686K	Buy	2,075 +216	+12%	+$69.6K	0.66%	62
2025 Q1	$612K	Hold	1,859	–	–	0.59%	62
2024 Q4	$513K	Hold	1,859	–	–	0.49%	62
2024 Q3	$644K	Hold	1,859	–	–	0.58%	62
2024 Q2	$615K	Hold	1,859	–	–	0.58%	62
2024 Q1	$675K	Hold	1,859	–	–	0.62%	62
2023 Q4	$557K	Hold	1,859	–	–	0.54%	62
2023 Q3	$532K	Buy	1,859 +1,062	+133%	+$303K	0.45%	62
2023 Q2	$224K	Hold	797	–	–	0.22%	62
2023 Q1	$204K	Sell	797 -6	-0.7%	-$1.75K	0.19%	62
2022 Q4	$266K	Buy	+803	New	+$254K	0.23%	61

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Weaver C. Barksdale & Associates's CI Position: Q2 2026 in Review

Weaver C. Barksdale & Associates reduced its Cigna (CI) stake by 0.6% in Q2 2026, selling an estimated $11.3K and leaving 6,654 shares worth $1.83M. The position accounts for 1.65% of the portfolio, ranked #31.

Weaver C. Barksdale & Associates first reported a position in CI in Q4 2022 and has held it in 15 quarters since. 1,702 funds tracked by Wall St. Rank hold CI as of Q2 2026.

Weaver C. Barksdale & Associates held 6,654 shares of Cigna worth $1.83M as of Q2 2026.
Weaver C. Barksdale & Associates sold 40 Cigna shares in Q2 2026, an estimated $11.3K.
Cigna made up 1.65% of Weaver C. Barksdale & Associates's portfolio in Q2 2026, its #31 holding.
Weaver C. Barksdale & Associates first reported a position in Cigna in Q4 2022 and has held it in 15 quarters since.
1,702 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.